MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from sale of
common stock in...
$30,380K
Proceeds from the
issuance of common stock...
$266K
Proceeds from maturities
of...
$284,700K
Proceeds from the
issuance of common stock...
$84K
Net cash provided by
financing activities
$30,428K
Net cash provided by
(used in) investing...
$14,004K
Canceled cashflow
$302K
Canceled cashflow
$270,696K
Net decrease in
cash, cash...
-$32,741K
Canceled cashflow
$44,432K
Stock-based compensation
expense
$14,183K
Depreciation and
amortization of property and...
$3,043K
Accrued expenses and
other liabilities
$1,665K
Prepaid expenses and
other current assets
-$952K
Non-cash operating lease
expense
$800K
Accounts payable
$627K
Asset impairment
$120K
Amortization of finance lease
right-of-use assets
$49K
Payment of deferred
offering costs related to...
$241K
Principal payments on
finance leases
$61K
Purchases of
held-to-maturity investments
$269,513K
Purchases of property and
equipment
$1,183K
Net cash used in
operating activities
-$77,173K
Canceled cashflow
$21,439K
Net loss
-$90,351K
Amortization and accretion of
premiums/discounts on...
$4,536K
Operating lease
liabilities
-$2,918K
Change in contingent
value rights...
-$743K
Other assets
$58K
Gain on lease
modification
$6K
Back
Back
Cash Flow
source: myfinsight.com
Neurogene Inc. (NGNE)
Neurogene Inc. (NGNE)